Qianzhan Investment Management is engaged in investment and fund management.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 5, 2023
Immune-Onc Therapeutics
|
Series B | $25M | Biopharma | — |
Jul 25, 2016
Tianxiang Ruiyi
|
Series A | ¥10M | Artificial Intelligence | — |